Geon-Ho Jahng1,2, Ji Yoon Lee3, Seung-Hyun Lim1, Hak Young Rhee4, Soonchan Park1,2, Jongho Lee5, and Chang-Woo Ryu1,2
1Radiology, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of, 2Medicine, Kyung Hee University, Seoul, Korea, Republic of, 3Biomedical Engineering, Kyung Hee University, Yongin-si, Korea, Republic of, 4Neurology, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of, 5Electrical and Computer Engineering, Seoul National University, Seoul, Korea, Republic of
1Radiology, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of, 2Medicine, Kyung Hee University, Seoul, Korea, Republic of, 3Biomedical Engineering, Kyung Hee University, Yongin-si, Korea, Republic of, 4Neurology, Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of, 5Electrical and Computer Engineering, Seoul National University, Seoul, Korea, Republic of
The ViSTa-GRASE sequence
provides the good MWF map in a reasonable scan time to evaluate myelin loss in
AD patients. MWF could serve as a
potential imaging biomarker for AD for evaluating demyelination and predicting
treatment outcomes.
Table 1. Summary of the statistical results of the demographic data.
Figure
1. Results of voxel-based
comparisons of myelin water fraction (MWF), gray matter volume (GMV), and white
matter volume (WMV) among the three participant groups.
